Teva Pharmaceuticals and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
Patient enrollment in the RELIEVE UCCD (ulcerative colitis and Crohn’s [...]
Patient enrollment in the RELIEVE UCCD (ulcerative colitis and Crohn’s [...]
Introduction In recent epochs, an escalating focus has converged upon [...]
“Northwell and its team of clinicians with expertise in memory [...]
Ann-Marie Orange, CIO & Global Head of R&D shares, “With [...]
“We are thrilled to partner with UltraSight to bring their [...]
“We designed the IntelAir to fulfill a market need; while [...]
“We believe that the NADMED method will advance science and [...]
Her journey eventually led to Widex Moment Sheer hearing aids. [...]
BIOTRONIK notes Over the past decades, more than 20 clinical [...]
This article intends to dissect these complexities, outlining the market, [...]